Invention Grant
- Patent Title: Antisense drugs against canine ICAM-1 for use in the treatment of inflammation of the buccal cavity
-
Application No.: US16634019Application Date: 2018-07-11
-
Publication No.: US11008574B2Publication Date: 2021-05-18
- Inventor: Georg Sczakiel , Rosel Kretschmer-Kazemi Far , Franziska Preuss
- Applicant: UNIVERSITÄT ZU LÜBECK
- Applicant Address: DE Lübeck
- Assignee: UNIVERSITÄT ZU LÜBECK
- Current Assignee: UNIVERSITÄT ZU LÜBECK
- Current Assignee Address: DE Lübeck
- Agency: Viksnins Harris Padys Malen LLP
- Priority: EP17001305 20170728
- International Application: PCT/EP2018/068750 WO 20180711
- International Announcement: WO2019/020371 WO 20190131
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K9/00
Abstract:
The present invention relates to an isolated antisense oligonucleotide for use in a method of preventing or treating an inflammatory disease or condition of the buccal cavity in a canine subject, wherein said antisense oligonucleotide is directed against canine ICAM-1. The present invention further relates to compositions or articles of manufacture comprising said antisense oligonucleotide.
Public/Granted literature
- US20200239894A1 ANTISENSE DRUGS AGAINST CANINE ICAM-1 FOR USE IN THE TREATMENT OF INFLAMMATION OF THE BUCCAL CAVITY Public/Granted day:2020-07-30
Information query
IPC分类:
